Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management
Simple Summary Obesity has been linked to several common cancers including breast,
colorectal, esophageal, kidney, gallbladder, uterine, pancreatic, and liver cancer. Obesity …
colorectal, esophageal, kidney, gallbladder, uterine, pancreatic, and liver cancer. Obesity …
Acetyl-CoA metabolism in cancer
DA Guertin, KE Wellen - Nature Reviews Cancer, 2023 - nature.com
Few metabolites can claim a more central and versatile role in cell metabolism than acetyl
coenzyme A (acetyl-CoA). Acetyl-CoA is produced during nutrient catabolism to fuel the …
coenzyme A (acetyl-CoA). Acetyl-CoA is produced during nutrient catabolism to fuel the …
TGFβ biology in cancer progression and immunotherapy
R Derynck, SJ Turley, RJ Akhurst - Nature Reviews Clinical Oncology, 2021 - nature.com
TGFβ signalling has key roles in cancer progression: most carcinoma cells have inactivated
their epithelial antiproliferative response and benefit from increased TGFβ expression and …
their epithelial antiproliferative response and benefit from increased TGFβ expression and …
Reprogramming of fatty acid metabolism in cancer
N Koundouros, G Poulogiannis - British journal of cancer, 2020 - nature.com
A common feature of cancer cells is their ability to rewire their metabolism to sustain the
production of ATP and macromolecules needed for cell growth, division and survival. In …
production of ATP and macromolecules needed for cell growth, division and survival. In …
Targeting FAK in anticancer combination therapies
JC Dawson, A Serrels, DG Stupack… - Nature Reviews …, 2021 - nature.com
Focal adhesion kinase (FAK) is both a non-receptor tyrosine kinase and an adaptor protein
that primarily regulates adhesion signalling and cell migration, but FAK can also promote …
that primarily regulates adhesion signalling and cell migration, but FAK can also promote …
CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate
CD36 is a type 2 cell surface scavenger receptor widely expressed in many immune and
non-immune cells. It functions as both a signaling receptor responding to DAMPs and …
non-immune cells. It functions as both a signaling receptor responding to DAMPs and …
The obese adipose tissue microenvironment in cancer development and progression
DF Quail, AJ Dannenberg - Nature Reviews Endocrinology, 2019 - nature.com
Obesity is associated with both increased cancer incidence and progression in multiple
tumour types, and is estimated to contribute to up to 20% of cancer-related deaths. These …
tumour types, and is estimated to contribute to up to 20% of cancer-related deaths. These …
[HTML][HTML] Obesity, diabetes, and increased cancer progression
DS Kim, PE Scherer - Diabetes & metabolism journal, 2021 - synapse.koreamed.org
Rates of obesity and diabetes have increased significantly over the past decades and the
prevalence is expected to continue to rise further in the coming years. Many observations …
prevalence is expected to continue to rise further in the coming years. Many observations …
Understanding the bone in cancer metastasis
J Fornetti, AL Welm, SA Stewart - Journal of Bone and Mineral …, 2018 - academic.oup.com
The bone is the third most common site of metastasis for a wide range of solid tumors
including lung, breast, prostate, colorectal, thyroid, gynecologic, and melanoma, with 70% of …
including lung, breast, prostate, colorectal, thyroid, gynecologic, and melanoma, with 70% of …
Emerging role of tumor cell plasticity in modifying therapeutic response
Resistance to cancer therapy is a major barrier to cancer management. Conventional views
have proposed that acquisition of resistance may result from genetic mutations. However …
have proposed that acquisition of resistance may result from genetic mutations. However …